On March 20, 2026, Novo Nordisk's patent on semaglutide expired in India, triggering one of the most significant transformations in the country's pharmaceutical history. Within weeks, more than 40 Indian…
🔬 How to Choose a Reliable Indian Generic Medicine Supplier: A Complete Buyer’s Guide India supplies approximately 20% of the world’s generic medicines by volume, exporting over USD 50 billion…
🔬 WHO-GMP Certification for Indian Generics: What the New Schedule M Rules Mean for You India supplies approximately 20% of the world's generic medicines by volume, making it the largest…
India is the largest supplier of generic medicines in the world, exporting over USD 50 billion worth of pharmaceuticals annually. Indian generics fill approximately 40% of the US generic drug…